🔎 Trials Near Me

Akèy › Kolit Ulseratif › Texas › Dallas

Etid klinik pou Kolit Ulseratif nan Dallas, TX

8 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Ap rekriteFaz 2
  • Ophthalmology Surgery Center of Dallas /ID# 284065, Dallas
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07697456

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

Ap rekriteFaz 3
  • University of Texas - Southwestern Medical Center /ID# 271835, Dallas
Laj 2 a 17 · Tout sèks · Mizajou Sep 30, 2026 · NCT07071519

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Ap rekriteFaz 1
  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Ap rekriteFaz 2
  • GI Alliance - Dallas - Gaston Avenue, Dallas
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07186101

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Ap rekriteFaz 4
  • GI Alliance - Digestive Health Associates of Texas, Dallas
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT06095128

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 3
  • The University of Texas Southwestern Medical Center - Site Number: 8400098, Dallas
Laj 16 a 80 · Tout sèks · Mizajou Aug 20, 2026 · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Ap rekrite
  • University of Texas Southwestern, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT05230173

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Ap rekriteFaz 2
  • Mirador Therapeutics Selected Site, Dallas
Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522

Etid Kolit Ulseratif nan lòt vil

Lòt etid nan Dallas

Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.